Compare SAM & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAM | ENOV |
|---|---|---|
| Founded | 1984 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Fluid Controls |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.5B |
| IPO Year | 1996 | 2008 |
| Metric | SAM | ENOV |
|---|---|---|
| Price | $182.40 | $25.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 9 |
| Target Price | ★ $233.70 | $47.38 |
| AVG Volume (30 Days) | 297.8K | ★ 1.1M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 95.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,964,994,000.00 | N/A |
| Revenue This Year | $1.02 | $6.36 |
| Revenue Next Year | $1.31 | $5.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $158.68 | $19.14 |
| 52 Week High | $264.46 | $34.28 |
| Indicator | SAM | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 51.08 | 43.72 |
| Support Level | $166.11 | $21.02 |
| Resistance Level | $188.90 | $27.51 |
| Average True Range (ATR) | 6.47 | 1.47 |
| MACD | 0.41 | -0.48 |
| Stochastic Oscillator | 69.17 | 4.13 |
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.